The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 17, 2024

Filed:

Sep. 27, 2021
Applicant:

Beta Bionics, Inc., Irvine, CA (US);

Inventors:

Michael J. Rosinko, Las Vegas, NV (US);

Himanshu Patel, Rancho Santa Margarita, CA (US);

Edward R. Damiano, Acton, MA (US);

Firas H. El-Khatib, Allston, MA (US);

Assignee:

Beta Bionics, Inc., Concord, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 5/172 (2006.01); A61M 5/142 (2006.01); A61M 5/168 (2006.01); G06F 3/04847 (2022.01); G06F 3/04883 (2022.01); G06F 8/61 (2018.01); G06F 8/65 (2018.01); G06F 8/656 (2018.01); G06F 21/30 (2013.01); G06F 21/31 (2013.01); G06F 21/62 (2013.01); G06F 21/84 (2013.01); G08B 21/04 (2006.01); G08B 21/18 (2006.01); G16H 10/60 (2018.01); G16H 20/17 (2018.01); G16H 40/40 (2018.01); G16H 40/60 (2018.01); G16H 40/67 (2018.01); G16H 50/30 (2018.01); G16H 80/00 (2018.01); H04L 9/08 (2006.01); H04L 9/30 (2006.01); H04L 9/40 (2022.01); H04L 67/00 (2022.01); H04W 76/10 (2018.01); H04W 76/14 (2018.01); A61B 5/145 (2006.01); G08B 25/00 (2006.01); G16H 40/00 (2018.01);
U.S. Cl.
CPC ...
G06F 8/656 (2018.02); A61M 5/142 (2013.01); A61M 5/14244 (2013.01); A61M 5/14248 (2013.01); A61M 5/16831 (2013.01); A61M 5/172 (2013.01); G06F 3/04847 (2013.01); G06F 3/04883 (2013.01); G06F 8/61 (2013.01); G06F 8/65 (2013.01); G06F 21/305 (2013.01); G06F 21/31 (2013.01); G06F 21/6245 (2013.01); G06F 21/84 (2013.01); G08B 21/0453 (2013.01); G08B 21/18 (2013.01); G16H 10/60 (2018.01); G16H 20/17 (2018.01); G16H 40/40 (2018.01); G16H 40/60 (2018.01); G16H 40/67 (2018.01); G16H 50/30 (2018.01); G16H 80/00 (2018.01); H04L 9/088 (2013.01); H04L 9/30 (2013.01); H04L 63/101 (2013.01); H04L 67/34 (2013.01); H04W 76/10 (2018.02); H04W 76/14 (2018.02); A61B 5/14532 (2013.01); A61M 2005/14208 (2013.01); A61M 5/1723 (2013.01); A61M 2005/1726 (2013.01); A61M 2205/18 (2013.01); A61M 2205/3327 (2013.01); A61M 2205/3546 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/3592 (2013.01); A61M 2205/50 (2013.01); A61M 2205/502 (2013.01); A61M 2205/505 (2013.01); A61M 2205/52 (2013.01); A61M 2205/581 (2013.01); A61M 2205/582 (2013.01); A61M 2205/583 (2013.01); A61M 2205/609 (2013.01); A61M 2230/201 (2013.01); G08B 25/00 (2013.01); G16H 40/00 (2018.01);
Abstract

An ambulatory medicament device can generate a dose control signal for delivery of medicament to a subject and secure at least some functionality of a user interface of the ambulatory medicament device. The ambulatory medicament device can have a locked state that restricts modification of at least one control parameter. The ambulatory medicament device can have an unlocked state that allows modification of at least one control parameter. The ambulatory medicament device can accept a user input of a security code that is validated against a passcode to enter from the locked state to the unlocked state.


Find Patent Forward Citations

Loading…